1. Canadian Task Force on the Periodic Health Examination. The periodic health examination. CMAJ
1979;121: 1193-254. [PMC free article] [PubMed] 2. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest
1986;89(suppl 2): 2-3S. [PubMed]
3. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Arch Intern Med
4. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest
1989;95: 2-4S. [PubMed] 5. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Antithrombotic therapy consensus conference. Chest
1992;102(suppl 4): 305-11S. [PubMed]
6. US Department of Health and Human Services, Public Health Service, Agency Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma. Rockville, MD: Agency for Health Care Policy and Research Publications, 1992. (AHCPR Pub 92-0038.)
7. Gyorkos TW, Tannenbaum TN, Abrahamowicz M, Oxman AD, Scott EA, Millson ME, et al. An approach to the development of practice guidelines for community health interventions. Can J Public Health
1994;85(suppl 1): S8-13. [PubMed] 8. Hadorn DC, Baker D. Development of the AHCPR-sponsored heart failure guideline: methodologic and procedural issues. Jt Comm J Qual Improv
1994;20: 539-54. [PubMed] 9. Cook DJ, Guyatt GH, Laupacis A, Sackett DL, Goldberg RJ. Clinical recommendations using levels of evidence for antithrombotic agents. Chest
1995;108(suppl 4): 227-30S. [PubMed] 10. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ, et al. Users' guide to the medical literature IX: a method for grading health care recommendations. JAMA
1995;274: 1800-4. [PubMed]
12. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams and Wilkins, 1996: xxxix-lv.
13. Eccles M, Clapp Z, Grimshaw J, Adams PC, Higgins B, Purves I, et al. North of England evidence based guidelines development project: methods of guideline development. BMJ
1996;312: 760-2. [PMC free article] [PubMed] 16. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, Dawes M. Levels of evidence and grades of recommendations. Oxford: Oxford Centre for Evidence-Based Medicine. www.cebm.net/levels_of_evidence.asp (accessed 8 Feb 2004). 18. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ
2001;323: 334-6. [PMC free article] [PubMed] 19. Roman SH, Silberzweig SB, Siu AL. Grading the evidence for diabetes performance measures. Eff Clin Pract
2000;3: 85-91. [PubMed] 20. Woloshin S. Arguing about grades. Eff Clin Pract
2000;3: 94-5. [PubMed] 21. Guyatt GH, Schünemann H, Cook D, Pauker S, Sinclair J, Bucher H, et al. Grades of recommendation for antithrombotic agents. Chest
2001;119: 3-7S. [PubMed]
22. Atkins D, Best D, Shapiro EN, eds. Third US Preventive Services Task Force: background, methods and first recommendations. Am J Prev Med
2001;20: 3(suppl):1- 108.
23. Woolf SH, Atkins D. The evolving role of prevention in health care: contributions of the US Preventive Services Task Force. Am J Prev Med
2001;20: 3(suppl):13-20. [PubMed] 24. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med
2001;20:3 (suppl): 21-35. [PubMed] 25. Briss PA, Zaza S, Pappaioanou M, Fielding J, Wright-De Aguero L, et al. Developing an evidence-based guide to community preventive services—methods. Am J Prev Med
2000;18 (suppl 1): 35-43. [PubMed] 26. Zaza S, Wright-De A, Briss PA, Truman BI, Hopkins DP, Hennessy MH, et al. Data collection instrument and procedure for systematic reviews in the guide to community preventive services. Am J Prev Med
2000;18(suppl 1): 44-74. [PubMed] 27. Greer N, Mosser G, Logan G, Halaas GW. A practical approach to evidence grading. Jt Comm J Qual Improv
2000;26: 700-12. [PubMed]
28. West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, et al. Systems to rate the strength of scientific evidence. Rockville, MD: Agency for Healthcare Research and Quality, 2002: 64-88. (AHRQ publication No 02-E016.)
29. Guyatt G, Drummond R, eds. Users' guide to the medical literature. Chicago, IL: AMA Press, 2002: 55-154.
30. Clarke M, Oxman AD, eds. Assessment of study quality. Cochrane reviewers' handbook 4.1.5 section 6. In: Cochrane Library. Issue 4. Oxford: Update Software, 2002.
31. Jüni P, Altman DG, Egger M. Assessing the quality of randomised controlled trials. In: Egger M, Davey Smith G, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001: 87-121.
32. West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, et al. Systems to rate the strength of scientific evidence. Rockville, MD: Agency for Healthcare Research and Quality, 2002: 51-63. (AHRQ publication No 02-E016.)
33. Kunz R, Vist G, Oxman AD. Randomisation to protect against selection bias in health-care trials (Cochrane methodology review). In: Cochrane Library Issue 4. Oxford: Update Software, 2002.
34. Ioannidis JP, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA
2001;286: 821-30. [PubMed]
35. Kleijnen J, Gøtzsche P, Kunz RA, Oxman AD, Chalmers I. So what's so special about randomisation? In: Chalmers I, Maynard A, eds. Non-random reflections on health care research: on the 25th anniversary of Archie Cochrane's effectiveness and efficiency. London: BMJ, 1997: 93-106.
36. Lacchetti C, Guyatt G. Surprising results of randomized controlled trials. In: Guyatt G, Drummond R, eds. Users' guide to the medical literature. Chicago, IL: AMA Press, 2002: 247-65.
37. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA
1998;280: 605-13. [PubMed] 38. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial. JAMA
2002;288: 321-33. [PubMed]
39. Dans A, McAlister F, Dans L, Richardson WS, Straus S, Guyatt G. Applying results in individual patients. In: Guyatt G, Drummond R, eds. Users' guide to the medical literature. Chicago, IL: AMA Press, 2002: 369-84.
40. McAlister F, Laupacis A, Wells G. Drug class effects. In: Guyatt G, Drummond R, eds. Users' guide to the medical literature. Chicago, IL: AMA Press, 2002: 415-31.
41. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med
1991;324: 781-8. [PubMed] 42. Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med
1990;322: 802-9. [PubMed] 43. Worster A, Preyra I, Weaver B, Haines T. The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: a meta-analysis. Ann Emerg Med
2002;40: 280-6. [PubMed] 44. Worster A, Haines T. Does replacing intravenous pyelography with noncontrast helical computed tomography benefit patients with suspected acute urolithiasis? Can Assoc Radiol J
2002;53: 241. [PubMed] 45. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: evidence from published meta-analyses. BMJ
2003;326: 472. [PMC free article] [PubMed] 46. Bross IDJ. Pertinency of an extraneous variable. J Chron Dis
1967;20: 487-95. [PubMed] 47. Thompson DC, Rivara FP, Thompson R. Helmets for preventing head and facial injuries in bicyclists. Cochrane Database Syst Rev
2000;(2): CD001855. [PubMed] 48. Devereaux PJ, Choi PT, Lacchetti C, Weaver B, Schünemann HJ, Haines T, et al. A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. CMAJ
2002;166: 1399-406. [PMC free article] [PubMed]
49. North of England Evidence Based Guideline Development Project. Evidence based clinical practice guideline: the choice of antidepressants for depression in primary care. Newcastle upon Tyne: Centre for Health Services Research, 1997.